🇺🇸

US SEC Filing Intelligence

· daily

Contract Option Exercises — October 13, 2026

Three civilian contract option exercises totaling $65,819,086 were recorded for the period, with zero defense-related awards. The dominant theme is civilian federal spending across GSA, HHS/CDC, and USDA Forest Service, with no clear defense-sector signal. The highest-materiality award is Perimeter Solutions LP's $21,328,521 USDA Forest Service retardant delivery order, which is the only contract with a meaningful 2026 revenue-recognition window, though only about 37% ($7,821,639) is outlayed. All three contracts carry neutral signals (average strength 3.3/10), and none of the recipients' public-company or parent-level financials are available to judge materiality. The key watch item is whether Perimeter's call-offs and outlays progress through its 2026-12-31 performance end, since most of the obligation remains undelivered.

3 total filings
· daily

Federal IT & Cybersecurity Contracts — October 13, 2026

This digest covers a single federal IT and cybersecurity contract totaling $21,908,995 in obligations, awarded to Digital Management LLC by the Centers for Disease Control and Prevention (HHS), a civilian agency; the defense/civilian split is 0 defense and 1 civilian. The dominant theme is civilian health-agency IT hosting, with the CDC's on-premises application hosting order carrying a firm-fixed-price structure awarded under full and open competition. The highest-conviction observation is that roughly 84% ($18,409,011) has already been outlayed, indicating substantial delivery progress, though the signal strength is low (3/10) and materiality is minimal (2/10) because the recipient's public-company status is not established. The key watch item is whether the order is exercised, modified, or extended beyond its current 2026-11-10 end date, since only about $3.5 million remains against the obligation. Overall the investment signal is neutral with no clear investable public-equity exposure identified from the data provided.

1 total filings
· daily

All HHS Contracts — October 13, 2026

This digest covers a single HHS contract record totaling $21,908,995 in obligation, with zero defense-related awards, making it a purely civilian data point. The sole award went to Digital Management LLC, a McLean, VA firm, through a firm-fixed-price delivery order from the CDC for on-premises application hosting in Atlanta, GA. Roughly $18,409,011 (about 84%) has been outlayed, leaving approximately $3.5 million against a performance end date of 2026-11-10. The highest-conviction read is that this is a contained, low-materiality IT services award with no identifiable public-company exposure, so it does not by itself support an investment thesis. The key watch item is whether the contract is exercised, modified, or extended beyond 2026-11-10, and whether the recipient has any public parent or ticker tie that would make it investable.

1 total filings
· daily

High-Value Federal Grants ($5M+) — October 13, 2026

Three high-value federal awards totaling $65,819,086 were recorded in this period, with none defense-related: all three sit in civilian agencies (GSA, HHS/CDC, USDA Forest Service). The dominant theme is civilian facilities, IT services, and fire-retardant supply rather than defense modernization, and all three signals are rated neutral with an average strength of 3.3/10. The highest-materiality award is Perimeter Solutions LP's $21,328,521 USDA Forest Service delivery order for FY26 retardant, which is the only one with a sizeable unbilled balance (about 63% still outstanding) tied to a 2026 wildfire-season cycle. The main watch item is that none of the three recipients' public-company status or parent financials is disclosed, so investability and materiality cannot be confirmed from this data alone; the CDC order's remaining roughly $3.5M and the GSA project's option exercise toward 2027 are the near-term observables.

3 total filings
· daily

General Federal Contracts — October 13, 2026

Three general federal contracts totaling $65,819,086 were analyzed for the period October 13, 2026, with zero defense-related awards, so the entire set falls on the civilian side of the ledger across GSA, HHS (CDC), and USDA (Forest Service). The most material award is Perimeter Solutions LP's $21,328,521 USDA Forest Service retardant delivery order (FY26 performance through 2026-12-31), which carries the highest materiality score (4/10) and the largest remaining unpaid balance at roughly $13.5 million. The dominant theme is civilian agency spending on operational and facilities needs rather than technology or defense modernization, and all three contracts were rated neutral with average signal strength of 3.3/10. The highest-conviction signal is the Perimeter Solutions wildfire-retardant obligation, which shows 37% outlayed with most volume still to be called off in 2026. The key watch item is whether Digital Management LLC's CDC hosting order, with about $3.5 million remaining against a 2026-11-10 end date, is exercised or extended, and whether the recipient's investability is ever established since its ownership status is undisclosed.

3 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 13, 2026

This digest covers ten Form 4 insider-transaction filings dated 2026-10-13 across six S&P 500 technology constituents: Cisco, Analog Devices, NVIDIA, Accenture, Arista Networks, Palantir, and CrowdStrike. All ten are Section 16 insider filings rather than periodic financial reports, so the enriched data contains no period-over-period revenue, margin, guidance, capital allocation, M&A, or financial ratio figures; those comparisons cannot be drawn from this stream and are not inferred here. The actionable content is insider behavior: seven of ten filings record open-market sales (Accenture, Arista, Palantir x2, CrowdStrike x2) and all of those are tagged as Rule 10b5-1 plan trades, which typically reduces the signal value of individual sales, while the remaining three filings are compensation-related (tax withholding, director award, equity award amendment) or a gift. The largest economic sale is Arista CEO Jayshree Ullal (about $20.2M across six transactions, reported holdings of about 15.4M shares), followed by CrowdStrike CEO George Kurtz (30 and 5 transactions across two filings, holdings about 7.48M shares, sold at roughly $262-$272). Sentiment tags are uniformly negative for the sales and neutral for compensation and gift filings. The dominant theme is routine, plan-driven insider monetization at elevated share prices rather than discretionary bearish conviction; no filing in this batch reports a purchase by any insider.

8 high priority 2 medium 10 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 13, 2026

The 12 filings for the USA NASDAQ-100 stream (dated 2026-10-13) are dominated by routine Section 16 insider reporting and proxy/capital-markets housekeeping rather than substantive financial disclosure. Insider activity is mostly tax-withholding and equity-award vesting at Intuitive Surgical, Cisco, Analog Devices, and NVIDIA, with the notable exceptions of open-market selling by Palantir directors and officers under Rule 10b5-1 plans and a director sale at Strategy Inc. Sales are concentrated at Palantir (roughly $4.6M combined across two insiders) and Strategy Inc (about $143K plus $68K), while Intuitive's withholding activity (about $549K and $450K) reflects compensation settlement rather than conviction. Period-over-period financial comparisons (YoY/QoQ values, margins, ratios) are not present in the enriched excerpts for this batch, so portfolio-level growth or margin trend claims cannot be substantiated from the data supplied. Forward-looking guidance and dated catalysts are also largely absent; the only dated items are the Strategy Inc press release (October 12, 2026) and the referenced August 3, 2026 proxy filing. Overall the signal content is low-materiality, with the Analog Devices CEO gift (13,305 shares, materiality 7/10) and Palantir's Rule 10b5-1 sales being the most attention-worthy items.

7 high priority 5 medium 12 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — October 13, 2026

Across 50 Schedule 13D/13G filings dated October 13, 2026, the dominant theme is passive institutional repositioning (JPMorgan, Royce, Millennium, Streeterville, Heights/CVI, Jane Street) rather than activist campaigns, with most filings being routine 13G amendments or exits. The most material developments are the Getty Images restructuring support agreement (Koch-affiliated KED Parties and majority shareholders, 45.5% aggregate holders) that cancels all public Class A equity and warrants with no distribution, a prepackaged Chapter 11 recapitalization that is severely negative for public holders, and the TETE/Bradbury Capital business combination that left insider Loo See Yuen with ~52.7% of shares after a $1.1B share-based deal. Insider and sponsor conviction signals are mixed: Ryan Cohen added to GameStop at $26.75-$27.00, Dr. Kukes and Kenneth Lehman added to PEDEVCO and BayFirst (39.4%) respectively, Drew Holdings (Troim) rapidly accumulated Borr Drilling (~9.6M shares in 60 days), while several large holders fully exited (Pacira ~2.94M shares at $36.29, Sono Group, Alpha Modus, Smith Douglas). Quantitative period-over-period data is sparse in these filings, so most trend analysis is qualitative; capital allocation and financial ratio data largely absent, limiting cross-company margin or growth comparisons. Overall market implication: holder-level stake changes are modest signals and should be weighed against underlying corporate events (restructuring, SPAC closings, dilution).

15 high priority 35 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 13, 2026

The 29 filings for the 2026-10-13 window are dominated by the Q3 2026 bank earnings cluster (Citigroup, JPMorgan, Wells Fargo, Goldman Sachs) plus a large volume of routine Progressive Corp Form 4 equity-award filings that carry little information. Across the four banks, headline earnings held up year over year (Citi revenue +8% YoY, JPM net income +6% YoY, Wells Fargo net income +6% YoY, Goldman revenue +23% YoY), but sequential momentum was weak almost everywhere: revenue fell QoQ at Citi (-4%), Wells (-3%) and Goldman (-8%), and Markets trading declined sharply QoQ (Wells Markets -17%, Goldman FICC -24%). The dominant bank-level risk is credit: Wells Fargo's provision for credit losses jumped to $11,029M from $681M a year earlier and $914M in Q2, while Citi's net ACL build rose to $333M from $145M, even as Citi's non-accrual loans fell 12% YoY. Outside the earnings cluster, insider activity was modest and mostly routine (Progressive RSU/phantom awards, a 10b5-1 sale by Mastercard director Genachowski, Robinhood's 10b5-1 sales of its Robinhood Ventures Fund stake, and Japan Post's continued 10b5-1 selling of Aflac stock). Several filings (JPM's 7.01 slide deck, T. Rowe Price OHA's fund proxy) carry little quantitative content and were treated accordingly.

24 high priority 5 medium 29 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 13, 2026

Two filings were reviewed for the USA S&P 500 Energy stream, both dated 2026-10-13. Occidental Petroleum's Q3 2026 8-K shows production within guidance despite a September Gulf of America curtailment tied to a third-party gas pipeline constraint and maintenance, with domestic lease operating cost at $8.54/boe and a $94 million reduction to operating cash flow from crude oil collar settlements. Realized pricing was uneven against benchmarks: worldwide oil realized $85.91/Bbl versus WTI at $85.79 and Brent at $91.62 (about 94% of Brent), NGL at 29% of WTI, and domestic gas at only 54% of NYMEX ($1.69/Mcf vs $2.97/Mcf), signaling weak Gulf-linked and Mid-Continent gas realizations. Expand Energy's 8-K is governance-only: a new Vice President and Chief Accounting Officer, Sarah Grose, replaces interim principal accounting officer and CFO Marcel Teunissen, with no disclosed change to operating or capital allocation metrics. The enriched period-over-period, insider, capital allocation, and forward-looking fields were not populated for either filing, so the synthesis rests on the summary and key-point data, and the digest's conviction is limited accordingly. The dominant theme is that gas realizations are lagging oil sharply, making infrastructure and takeaway capacity the key swing factor for producer cash flow.

1 high priority 1 medium 2 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 13, 2026

Three filings dated 2026-10-13 from the S&P 500 Consumer Staples stream were reviewed, but the enriched data supplied is thin: none of the filings carries period-over-period financial comparisons, quantified forward-looking guidance, capital-allocation trend data, or ratio disclosures. The most material development is Kimberly-Clark's early tender results for Kenvue notes tied to the pending Kenvue acquisition (up to $7.0 billion in new notes, expected close Q4 2026, offers expiring October 27, 2026 unless extended), where consents were received to strip most covenants from the Kenvue indenture. Procter & Gamble's filing is routine, confirming a $1.0885 quarterly dividend (record date October 23, 2026) and election of all twelve directors per preliminary results, with no financial news. McCormick's Form 4 reflects a small phantom stock award to the Chairman/CEO (~$2.51K), which is a compensation grant rather than an open-market conviction signal. Portfolio-level patterns cannot be credibly quantified from this set, so the digest focuses on time-sensitive catalysts and transaction mechanics rather than trend synthesis.

1 high priority 2 medium 3 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 13, 2026

Two S&P 500 Industrials filings were published in this window, both SEC 8-K disclosures, and neither carries the rich enriched fields (insider trading, capital allocation, guidance, transaction valuations) that would support a deep quantitative digest. Emerson Electric's recast of prior results is the more substantive item: the restatement for mark-to-market pension accounting is largely neutral to headline profitability, with nine-month FY2026 net earnings to common stockholders edging up from $1,941M to $1,947M and diluted EPS moving from $3.45 to $3.46, while fiscal 2025 full-year net earnings were revised down from $2,293M to $2,270M (diluted EPS $4.04 to $4.00) even as adjusted EPS was nudged up from $6.00 to $6.01. The restatement also flags an $82M benefit from IEEPA tariff refunds in Q3 FY2026 that is excluded from adjusted metrics, which is a useful reminder that reported and adjusted earnings are diverging in ways investors should track. CSX's disclosure is a management transition: COO Mike Cory is retiring, with operations and network leadership (Doug Ryhorchuk, Casey Albright) now reporting directly to CEO Steve Angel, and no financial metrics were disclosed. Taken together, the stream shows no sector-wide margin or guidance trend that can be drawn from this small sample, so the actionable takeaways are about earnings-quality monitoring at Emerson and operational continuity at CSX.

1 high priority 1 medium 2 total filings
· daily

US Material Events SEC 8-K Filings — October 13, 2026

The 50-filing Material Events Monitor for 2026-10-13 is dominated by capital-structure stress and governance churn among micro- and small-caps: AMBP's automatic 15% principal step-up and dilution tied to an unachieved uplist, Co-Diagnostics' restrictive senior secured factor-rate loan with ATM sweep, Hyperscale Data's ATM sales of 121.8M shares at about $0.41, Sino Green Land and Mitesco debt-to-equity and bridge-note maneuvers, and ADC Therapeutics' $86.6M PIPE and debt restructuring. Large-cap M&A is active, led by STERIS's $2.1B Xodus Medical acquisition, IonQ's up-to-$1.3B all-stock Elisity deal, SSR Mining's C$6.75 Roxmore cash bid, Select Water's $800M notes offering to fund Pilot Water, and the Kenvue/Kimberly-Clark consent solicitation stripping covenants from $7.75B of notes. Going-concern and distress signals are concentrated in PREM (lease defaults, CEO exit, RIF), Getty Images (prepackaged Chapter 11 with equity cancellation), Dot Ai (Nasdaq equity shortfall and majority dilution to BladeRanger), and EON Resources (FY2025 DD&A restatement reducing the loss from $10.1M to about $7.5M). Governance transitions are frequent, including Bausch + Lomb's interim CEO, Mueller Water's CFO handoff, Nuvve's audit and compensation chair exits, and Xponential's poison pill amid a strategic review. Quantitative period-over-period comparisons are sparse in the supplied enriched fields, so most cross-company trend reads are qualitative and should be confirmed against source filings.

50 high priority 50 total filings
· daily

Insider Trading Pulse — October 13, 2026

Across 50 Form 4 insider filings dated 2026-10-13, the stream is dominated by routine equity compensation (grants of stock options, RSUs, phantom units and share awards at Cadrenal, Nano-X, Progressive, Soligenix, H.B. Fuller and others) and tax-withholding dispositions, which carry little directional signal. The genuinely informative transactions are open-market purchases: Saratoga Investment CEO Christian Oberbeck bought ~30,000 shares near $14.85 (~$445K total, materiality 8/10), Borr Drilling director Olav Troim bought 2.5M shares at $4.74 (~$11.8M) and now holds ~37.3M shares, and Saba Capital accumulated stakes in Ellsworth and Gabelli Healthcare while selling in BlackRock ESG and PIMCO Dynamic Income. The main sell-side signal is large: GIC Private sold ~7.8M Medline Class A shares at $35.15 (~$275M), the single largest dollar disposition in the set, while Guidewire's CEO and CAO sold under 10b5-1 plans at ~$168-169. Insider purchases are concentrated in small-cap and closed-end/fund names, and many 10b5-1 sales are pre-scheduled and should be discounted. Period-over-period comparisons are not supplied in these filings, so margin and growth trends cannot be quantified from the data provided and should be verified against the underlying 10-Q/10-K financials.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 13, 2026

Across the ten filings dated 2026-10-13, the Dow Jones 30 picture is one of resilient headline growth masking weakening underlying trends. Banks reported strong YoY top-line gains (Goldman Sachs net revenues +23% YoY; JPMorgan managed net revenue +8% YoY) but sharp QoQ declines in trading and investment banking (Goldman GBM -13% QoQ, FICC -24% QoQ; JPMorgan IB fees -8% QoQ). Healthcare showed the sharpest divergence: UnitedHealth's earnings from operations rose to $6.6B from $4.3B, but this was flattered by $610M of favorable prior-period reserve development and membership fell by roughly 1.2M across segments. Johnson & Johnson's GAAP EPS collapsed to $0.09 on a talc charge, while adjusted EPS fell 7.5% and STELARA imposed a ~690 bps drag on Innovative Medicine; management nonetheless raised full-year adjusted EPS guidance midpoint to $11.10. Capital return and governance items (P&G dividend of $1.0885, Merck board addition, insider tax withholdings at Cisco and NVIDIA) were routine and low-materiality. Net read: quality of earnings is the central question, and several headline beats rest on one-time or reserve items.

4 high priority 6 medium 10 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 13, 2026

All five filings sit squarely in the stream's distress scope (Nasdaq/NYSE delisting notices, going-concern disclosure, and balance-sheet stress), and none carries the forward-looking guidance, insider-trading, or capital-allocation enrichment the brief anticipates, so the synthesis rests mainly on the stated filing facts. The dominant theme is listing-compliance distress: three of five filings (ClearOne, Newton Golf, Equus) cite exchange deficiencies, two of which (ClearOne, Newton Golf) involve the $2.5 million minimum stockholders' equity test under Nasdaq Rule 5550(b)(1), a direct signal of capital erosion. Visium Technologies shows the clearest quantified deterioration: operating cash burn widened 122% to $(913,888), cash fell 63% to $22,212, and FY net income of $856,102 was produced entirely by a $2,923,004 debt-extinguishment gain rather than operations, while ~1.27 billion shares outstanding plus ~1.32 billion potential shares signal heavy dilution. CN Healthy Food Tech is the outlier, with a Nasdaq Panel keeping it listed under a one-year monitor after a disclosure omission regarding a CSRC filing, a governance rather than solvency issue. The near-term catalyst cluster is the October 13-20, 2026 window, when hearing-request and appeal deadlines determine whether ClearOne, Newton Golf and Equus face imminent suspension.

5 high priority 5 total filings
· daily

Global High-Priority Regulatory Events — October 13, 2026

The 50-filing US SEC and cross-border 'Global High Priority Market Events' stream is dominated by distress and listing-compliance events rather than growth catalysts: multiple Nasdaq and NYSE delisting notices (ClearOne, Newton Golf, Quetta Acquisition, Allurion, SilverBox IV, Bone Biologics warrants), a cluster of SPAC extension and redemption battles (Starry Sea, IX Acquisition, Quetta, Rising Dragon, Eureka), and a heavy Indian insolvency and restructuring flow (Tayo Rolls, Hi-Tech Gears, SKIL Infrastructure, Siti Networks, Sun Granite, Quadrant Televentures). Large-cap corporate actions are concentrated in the Ambuja Cements/ACC/Orient Cement amalgamation (NCLT hearing November 19, 2026) and the Medtronic/MiniMed exchange offer, which was oversubscribed with a preliminary proration factor of about 18.3%. Period-over-period data is mixed: Hero Motors' consolidated revenue rose 24.87% YoY but profit fell 32.60% QoQ, GTPL Hathway's revenue rose 16.0% YoY while it swung to a net loss and receivables more than doubled, and Dr. Lal PathLabs' subsidiary CPL saw turnover fall about 13.5% in FY26. Several filings lacked enriched financial, insider, or forward-looking fields, so conclusions on insider behaviour and guidance are limited to the filings that disclosed them. The most material near-term catalysts are the October 14, 15 and 19 trading suspensions and hearing deadlines, followed by the November 6 NCLAT hearing for Hi-Tech Gears and the November 19 NCLT hearing for the Ambuja/ACC/Orient amalgamations.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 13, 2026

Across 50 filings dated 2026-10-13, the day's flow is dominated by corporate-event and governance disclosures rather than fresh earnings, with several high-materiality stories: Nasdaq delisting actions (ClearOne equity-deficiency notice, Quetta SPAC 36-month-deadline delisting), a Nasdaq-driven SPAC redemption wave (Quetta, Starry Sea, IX Acquisition), and restatements (Fusion Fuel FY2025 20-F/A, EON Resources 10-K DD&A error). Period-over-period data is mixed: Domino's Q3 2026 shows top-line growth (+3.4% revenue, +12.7% diluted EPS) masking decelerating U.S. same-store sales (+0.3% company-owned versus 3.4% a year earlier) and a $1.33B current-debt reclassification; ASE Technology posted strong revenue growth (+44.8% YoY Q3) with Segment 2 momentum lagging Segment 1; ImmuCell's Q3 sales rose 46% YoY, flattered by a depressed prior-year base. Corporate transformation is a theme, with Aegon's redomiciliation to Delaware and a U.S. GAAP transition (Transamerica first-half operating results +10% YoY) and Humana's CenterWell joint venture that may move GAAP EPS while affirming Adjusted EPS of at least $9.00. Capital markets are active: IonQ's up-to-$1.3B all-stock Elisity acquisition, Drilling Tools' Nordic bond marketing ahead of the Saltire deal, and a Growth Capital convertible note for SS Innovations. Insider flow is light; the one Form 4 (Sea Ltd) is a small 10b5-1 sale.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 13, 2026

This digest covers a single Form 4 filing from Carvana Co. (CVNA), an S&P 500 Consumer Discretionary constituent, filed for the period ending 2026-10-13. The only enriched event is a Rule 10b5-1 plan sale by President, Special Projects Taira Thomas of 5,597 Class A shares at $65.00 (approximately $364K), leaving Thomas with 357,442 shares. Because the filing carries no period-over-period financials, guidance, capital allocation, or M&A data, no sector-level trend aggregation or cross-company comparison is possible from this stream today. The sentiment is classified as negative and materiality as 4/10, which reflects the modest dollar size and the pre-arranged nature of the sale rather than a material shift in conviction. Market implication: a routine plan-based insider sale is a weak signal on its own, and the investor takeaway is to monitor for additional filings rather than act on this one.

1 high priority 1 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 13, 2026

Across the ten S&P 500 Healthcare filings, the dominant theme is a split between earnings-quality noise and genuine guidance strength. UnitedHealth and Johnson & Johnson both raised full-year EPS guidance, yet UNH's Q3 operating earnings were flattered by $610 million of favorable prior-period reserve development and J&J's GAAP EPS collapsed to $0.09 on a talc litigation charge, so headline numbers need to be stripped of one-offs before they are trusted. Volume and membership trends are weakening at the managed-care end: UNH revenue slipped to $112.7 billion from $113.2 billion, Optum Health revenue fell 10% YoY, and Medicare Advantage membership shrank by 935,000 since year-end 2025. Capital-structure and governance activity is heavy but largely procedural, including Humana's CenterWell joint venture restructuring that removes a WCAS put option, Medtronic's oversubscribed MiniMed exchange offer with an estimated 18.3% proration, and several board appointments at Zoetis, Merck and Danaher. Insider activity at Intuitive Surgical is limited to routine tax withholding on RSU vestings at $423.96 per share, which signals no material conviction either way. Overall the sector picture is one of guidance held or raised by the largest names, offset by reserve-driven and litigation-driven distortions that will matter for Q4 2026 comparisons.

7 high priority 3 medium 10 total filings